SAFE, PRIVATE & SECURE
Your iOPharma™ account is password protected and safe from prying eyes. All iOPharma™ plans include SSL security - the same as online banks. Your data is secure.
SUPPORT FOR MULTIPLE LANGUAGES
iOPharma™ will be translated into Chinese, Spanish, French, German and Portuguese. More languages will be added to this list as time goes on. To find out more about the translations, please contact us at info@io-pharma.com.
FREE REGISTRATION
Whether you’re a buyer or a supplier the iOPharma™ platform will benefit your organisation.
REGISTER NOW
Cleveland Clinic researchers identify urgent need for Alzheimer's drug development
Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever...
Read morePharma industry backs UK antibiotics plan
GSK and ABPI back David Cameron’s call for global action on antimicrobial resistance.
Read moreAmgen receives FDA Breakthrough Therapy Designation for investigational BiTE® antibody blinatumomab in acute lymphoblastic leukemia
Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted...
Read moreIs the next 'new' cancer drug already in your medicine cabinet?
It turns out that the same types of drugs that help reduce watery eyes and runny noses during...
Read moreFDA issues guidance to support the responsible development of nanotechnology products
Three final guidances and one draft guidance were issued by the U.S. Food and Drug Administration...
Read moreBoehringer Ingelheim Statement on Hepatitis C drug development
Boehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the...
Read moreJames C. Smith elected to Pfizer's Board of Directors
Pfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective...
Read moreAbbott to acquire Veropharm
Abbott (NYSE: ABT) has announced a definitive agreement to acquire Veropharm, a leading Russian...
Read moreDiabetes drug appears to work for weight management, reversing prediabetes
Nondiabetic obese and overweight people lose more weight, are more likely to reverse prediabetes...
Read moreSanofi and Medtronic to form strategic alliance
Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) have signed a memorandum of...
Read more